Bio Rad Laboratories Stock Current Valuation
| BIO-B Stock | USD 325.85 0.00 0.00% |
Valuation analysis of Bio Rad Laboratories helps investors to measure Bio Rad's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. The current year's Enterprise Value is expected to grow to about 1 B, whereas Enterprise Value Over EBITDA is projected to grow to (16.29). Fundamental drivers impacting Bio Rad's valuation include:
Price Book 1.2183 | Enterprise Value 9 B | Enterprise Value Ebitda (13.07) | Price Sales 3.5803 | Forward PE 28.6533 |
Overvalued
Today
Please note that Bio Rad's price fluctuation is very steady at this time. Calculation of the real value of Bio Rad Laboratories is based on 3 months time horizon. Increasing Bio Rad's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Bio Rad is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Bio Stock. However, Bio Rad's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 325.85 | Real 209.79 | Hype 320.25 |
The real value of Bio Stock, also known as its intrinsic value, is the underlying worth of Bio Rad Laboratories Company, which is reflected in its stock price. It is based on Bio Rad's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Bio Rad's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Bio Rad Laboratories helps investors to forecast how Bio stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Bio Rad more accurately as focusing exclusively on Bio Rad's fundamentals will not take into account other important factors: Bio Rad Laboratories Company Current Valuation Analysis
Bio Rad's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Bio Rad Current Valuation | 9 B |
Most of Bio Rad's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bio Rad Laboratories is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Bio Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Bio Rad is extremely important. It helps to project a fair market value of Bio Stock properly, considering its historical fundamentals such as Current Valuation. Since Bio Rad's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Bio Rad's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Bio Rad's interrelated accounts and indicators.
Click cells to compare fundamentals
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Bio Rad Laboratories has a Current Valuation of 9 B. This is 37.32% lower than that of the Life Sciences Tools & Services sector and 15.48% higher than that of the Health Care industry. The current valuation for all United States stocks is 45.84% higher than that of the company.
Bio Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bio Rad's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bio Rad could also be used in its relative valuation, which is a method of valuing Bio Rad by comparing valuation metrics of similar companies.Bio Rad is currently under evaluation in current valuation category among its peers.
Bio Fundamentals
| Return On Equity | -0.0979 | ||||
| Return On Asset | 0.0186 | ||||
| Profit Margin | (0.30) % | ||||
| Operating Margin | 0.1 % | ||||
| Current Valuation | 9 B | ||||
| Shares Outstanding | 5.07 M | ||||
| Shares Owned By Insiders | 97.96 % | ||||
| Shares Owned By Institutions | 0.08 % | ||||
| Number Of Shares Shorted | 2 | ||||
| Price To Earning | 17.05 X | ||||
| Price To Book | 1.22 X | ||||
| Price To Sales | 3.58 X | ||||
| Revenue | 2.67 B | ||||
| Gross Profit | 1.57 B | ||||
| EBITDA | (608.26 M) | ||||
| Net Income | (637.32 M) | ||||
| Cash And Equivalents | 858.99 M | ||||
| Cash Per Share | 28.81 X | ||||
| Total Debt | 1.41 B | ||||
| Debt To Equity | 13.90 % | ||||
| Current Ratio | 4.57 X | ||||
| Book Value Per Share | 267.46 X | ||||
| Cash Flow From Operations | 374.94 M | ||||
| Short Ratio | 0.50 X | ||||
| Earnings Per Share | (28.09) X | ||||
| Price To Earnings To Growth | 1.21 X | ||||
| Number Of Employees | 7.7 K | ||||
| Beta | 0.94 | ||||
| Market Capitalization | 9.24 B | ||||
| Total Asset | 12.3 B | ||||
| Retained Earnings | 9.26 B | ||||
| Working Capital | 2.53 B | ||||
| Net Asset | 12.3 B |
About Bio Rad Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bio Rad Laboratories's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bio Rad using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bio Rad Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Bio Rad Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio Rad's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Rad Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Rad Laboratories Stock:Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.